San Antonio, TXNCT05604560Now EnrollingIRB Ready

Pancreatic Cancer Clinical Trial in San Antonio, TX

Access cutting-edge pancreatic cancer treatment through this phase 2 clinical trial at a research site in San Antonio. Study-provided care at no cost to qualified participants.

Sponsored by Lei Zheng

Quick Self-Assessment

See if you qualify for this San Antonio location

Preparing your pre-screening questions…

Expert Care in San Antonio

Access pancreatic cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related pancreatic cancer treatment provided free

Apply for This San Antonio Location

Check if you qualify for this pancreatic cancer clinical trial in San Antonio, TX

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to San Antonio

    Convenient for TX residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit San Antonio site if eligible
  4. 4Begin participation

About This Pancreatic Cancer Study in San Antonio

The purpose of this study is to evaluate the safety and clinical activity of tislelizumab (an anti-PD-1 antibody) in combination with SX-682 (a CXCR1/2 inhibitor) in subjects with newly diagnosed and surgically resectable pancreatic adenocarcinoma.

Sponsor: Lei Zheng

Who Can Participate

Inclusion Criteria

Ability to understand and willingness to sign a written informed consent document.
Age ≥18 years.
Newly diagnosed have histologically or cytologically proven adenocarcinoma of the pancreas.
Tumor must be resectable.
Patient's acceptance to have a tumor biopsy.
ECOG performance status 0 or 1
Patients must have adequate organ and marrow function defined by study-specified laboratory tests.
For both Women and Men, must use acceptable form of birth control while on study.

Exclusion Criteria

Have received any anti-pancreatic cancer therapy.
Have been diagnosed with another malignancy whose natural history or treatment has the potential to interfere with safety or efficacy assessment of this study.
Conditions, including alcohol or drug dependence, intercurrent illness, or lack of sufficient peripheral venous access, that would affect the patient's ability to comply with study visits and procedures
Subjects with active, known or suspected autoimmune disease that may relapse.
Systemic steroid therapy (\> 10mg daily prednisone equivalent) or immunosuppressive therapy within 14 days of first dose of study drug administration.
Active infection requiring systemic therapy.
Infection with HIV or hepatitis B or C at screening•
History of interstitial lung disease, non-infectious pneumonitis or uncontrolled diseases including pulmonary fibrosis, acute lung diseases, etc.
Uncontrolled intercurrent illness including, but not limited to, uncontrolled infection, pulmonary embolism, uncontrolled hypertension, symptomatic congestive heart failure, unstable angina, cardiac arrhythmia, metastatic cancer, or psychiatric illness/social situations that would limit compliance with study requirements.
Prior allogeneic stem cell transplantation or organ transplantation
Any major surgical procedure requiring general anesthesia ≤ 28 days before first dose of study drug.
Have received a live vaccine ≤ 28 days before first dose of study drug.
Use of QT prolonging drugs within 2 weeks before the start of SX-682 dosing and for the length of the study.
ECG demonstrating a QTc interval ≥ 470 msec or patients with congenital long QT syndrome.
Severe hypersensitivity reaction to any monoclonal antibody.
Concurrent participation in another therapeutic clinical study
Pregnant or breastfeeding

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in San Antonio?

Yes, this clinical trial (NCT05604560) has an active research site in San Antonio, TX that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Pancreatic Cancer Treatment Options in San Antonio, TX

If you're searching for pancreatic cancer treatment options in San Antonio, TX, this clinical trial (NCT05604560) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our San Antonio research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced pancreatic cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all pancreatic cancer clinical trials near you to find additional studies recruiting in your area.

More Pancreatic Cancer Trials in San Antonio, TX

See all pancreatic cancer clinical trials recruiting in San Antonio — not just this study.

Browse Pancreatic Cancer Trials in San Antonio →

Browse More Trials by Condition

Pancreatic Cancer TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in San Antonio?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · San Antonio, TX